Found 9 matching trials
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
PHASE1This is a multicenter, open-label, phase Ib/II study on the efficacy and sa...
Location
Chongqing University Cancer Hospital
A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma
PHASE2This study was an open, single-arm, enriched, multicenter Phase II study....
Location
Shandong New Time Pharmaceutical Co., LTD
A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE2This is a single-arm, open-label, and multicenter phase Ⅱ study designed to...
Location
Cancer Hospital, Chinese Academy of Medical Sciences
A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)
PHASE2It is a multi-center, prospective, open-label, two-stage optimized design, ...
Location
Multiple Locations
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)
PHASE2The purpose of this study is to evaluate the efficacy and safety of F520 co...
Location
Shanghai tumor hospital
Phase Ⅰ Study to Evaluate the Safety and Tolerability of Using F520
PHASE1Recombinant Programmed death-1(PD-1) humanized monoclonal antibody injectio...
The Efficacy and Safety of F520 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (PTCL).
PHASE2It is a multi-center, prospective, open-label, two-stage optimized design, ...
Location
Multiple Locations
A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma
PHASE2This is a multicenter, Phase 2 study to evaluate the efficacy and safety of...
Location
Multiple Locations
A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL
PHASE2This is an open-label, single-arm, and multicenter phase Ⅱ study designed t...
Location
Multiple Locations